Euglena (2931) Stock Overview

Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae in Japan. The company operates through two segments, Healthcare Business and Energy/Environment Business. It also manufactures and sells foods and cosmetics using euglena. In addition, the company develops biofuel technology and environmental related technology for microalgae; and invests in biotechnology related business. Further, it produces, processes, and sells euglena, chlorella, and other types of algae; cultivates and sells Japanese tiger prawns; sells supplements and health foods; and manufactures and sells organic compound fertilizer. Additionally, the company provides genome analysis services; corporate marketing support services; planning, development, and online shopping services for skincare products, miscellaneous goods, and food products. Euglena Co., Ltd. was incorporated in 2005 and is headquartered in Tokyo, Japan.